(DL)-2-amino-2-[3-hydroxy-4-(hydroxymethyl)phenyl]acetic acid

ID: ALA4101153

PubChem CID: 13013954

Max Phase: Preclinical

Molecular Formula: C9H11NO4

Molecular Weight: 197.19

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(C(=O)O)c1ccc(CO)c(O)c1

Standard InChI:  InChI=1S/C9H11NO4/c10-8(9(13)14)5-1-2-6(4-11)7(12)3-5/h1-3,8,11-12H,4,10H2,(H,13,14)

Standard InChI Key:  JRBXPUUAYKCCLQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 14 14  0  0  0  0  0  0  0  0999 V2000
   10.8018  -11.1699    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8018  -10.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5109   -9.9441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5109   -9.1269    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2200  -10.3527    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0969   -9.9441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3878  -10.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6828   -9.9441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6828   -9.1269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3878   -8.7183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0969   -9.1269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9737   -8.7183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2646   -9.1269    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9737  -10.3527    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  6 11  1  0
  9 12  1  0
 12 13  1  0
  8 14  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4101153

    CID 13013954

Associated Targets(non-human)

Slc1a5 Amino acid transporter (271 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 197.19Molecular Weight (Monoisotopic): 197.0688AlogP: -0.03#Rotatable Bonds: 3
Polar Surface Area: 103.78Molecular Species: ACIDHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 1.62CX Basic pKa: 8.24CX LogP: -2.54CX LogD: -2.60
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.54Np Likeness Score: 0.88

References

1.  (2014)  D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders, 

Source